Total Credits: 1 including 1 AMA PRA Category 1 Credit(s)™, 1 AOA Category 1-A Credit(s)
** Please note this program was a part of the VOC 2023. You will not want to choose this program if you completed this individual program as part of the VOC 2023. **
• Learners will recognize the most up-to-date hyperlipidemia treatment guidelines, novel pharmacotherapeutic agents, and their associated clinical trials.
• Learners will analyze data on patient labs in the context of patients’ individual circumstances.
• Learners will develop a comprehensive treatment and monitoring plan by incorporating the most up-to-date blood cholesterol treatment guidelines for patients.
• Learners will develop a good rapport with patients to engage them in the decision-making process.
• Learners will integrate the updated treatment guidelines and the newest evidence from clinical trials to create a plan to improve their patients' lipid profiles and thus decrease part of the risk factor profile for cardiovascular events.
Accreditation Statement: This program is co-sponsored by the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and the Osteopathic Physicians and Surgeons of Oregon (OPSO). Both osteopathic associations are accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.
The program has been designated for a maximum of one (1) AOA Category 1-A credit(s) by the co-sponsors who have authorized the Missouri Association of Osteopathic Physicians and Surgeons to report CME and specialty credits to the AOA commensurate with the extent of the physician's participation in this activity.
MAOPS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MAOPS designates this conference for a maximum of one (1) AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure: The Virtual CME Committee consisting of representatives from the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and the Osteopathic Physicians and Surgeons of Oregon (OPSO), has no relevant financial relationships with any organization producing, marketing, reselling, distributing health care goods or services consumed by, or used on, patients relative to the content of these presentations.
Osteopathic Grievance Policy: All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Virtual CME Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, they can then submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
|Handout - Sa5B) Dr. Clipper Young, PharmD - Update on Hyperlipidemia Guidelines- Beyond the Statins - OPSO (3.46 MB)
|Available after Purchase
Dr. Clipper Young is the Co-Director for Distance Learning & Clinical Integration, Associate Professor, and Clinical Pharmacist at Touro University California College of Osteopathic Medicine in Vallejo, California. He specializes in diabetes management/consultation, cardiovascular risk reduction, and medication therapy management. He received his Doctor of Pharmacy from the College of Pharmacy at Touro University California in Vallejo, California, and his Master of Public Health degree from the School of Public Health at Touro University California. Dr. Young is board certified in Advanced Diabetes Management and Diabetes Care & Education Specialist by the Association of Diabetes Care & Educational Specialists. He is also board certified as a Geriatric Pharmacist by the Board of Pharmacy Specialties.
Dr. Young was trained in an education-focused fellowship and continued his career working with patients, students, and healthcare professionals in various capacities. As an academic and community-based clinician, Dr. Young aspires to devote his career to lifelong learning as a clinical pharmacist, a public health advocate, and an educator. Being in the unique position of working with an interdisciplinary diabetes team at Touro University California College of Osteopathic Medicine as a faculty member, he has been able to integrate his education, training, and passion for pursuing his dream of tackling diabetes.
Dr. Young discloses that he is a speaker for Abbott and does community outreach support through a grant from Sutter Health. All relevant financial relationships have been mitigated.